Étiquette : auto experimentation

The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity, Ido Hartogsohn, 2018

The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity Ido Hartogsohn Frontiers in Neurosciences, 06 March 2018 | https://doi.org/10.3389/fnins.2018.00129 Past research has demonstrated to the ability of psychedelics to enhance suggestibility, and pointed to their ability to amplify perception of meaning. This paper examines the existing evidence for the meaning-enhancing properties of psychedelics, and argues that the tendency of these agents to enhance the perception of significance offers valuable clues to explaining their reported ability to stimulate a variety of therapeutic processes, enhance creativity, and instigate mystical-type experiences. Building upon previous research, which suggested the potential role of [...]

Lire la suite

Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics, Natasha L. MASON and Kim P. C. KUYPERS, 2018

Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics Natasha L. MASON and Kim P. C. KUYPERS Journal of Psychedelic Studies, 2018,  2, (1), pp. 45–52 DOI: 10.1556/2054.2018.006   Background : A substantial number of people worldwide suffer from mental health problems during their lifetime. First-line treatments are not effective for everybody. Recent studies suggest that psychedelic drugs have high therapeutic potential for a variety of mental disorders. Aims : This survey study aimed to assess the tendency of psychedelic users to self-medicate with psychedelics and to compare the effectiveness of self-administered psychedelics to treat their disorder and the treatment offered [...]

Lire la suite

The hyperassociative mind : The psychedelic experience and Merleau-Ponty’s “wild being”, Csaba SZUMMER et al., 2017

The hyperassociative mind: The psychedelic experience and Merleau-Ponty’s “wild being” CSABA SZUMMER, LAJOS HORVÁTH, ATTILA SZABÓ, EDE FRECSKA and KRISTÓF ORZÓI Journal of Psychedelic Studies, 2017, 1, (2), pp. 55–64 DOI: 10.1556/2054.01.2017.006   Purpose : In contemporary phenomenology, Dieter Lohmar has suggested that the new task of phenomenological research is to analyze the “alternative representational systems” of fantasy. In line with this program, we propose that psychedelic experience could also be suitable subject to this project subsumed under the wider category of fantasy activity. The aim of this paper is to show that psychedelic experiences offer a favorable situation to study the imagination. Method : The [...]

Lire la suite

The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training, Elizabeth M. Nielson et al., 2018

The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training ELIZABETH M. NIELSON and JEFFREY GUSS Journal of Psychedelic Studies, 2018 DOI: 10.1556/2054.2018.009   Abstract Clinical research on psychedelic-assisted psychotherapy is rapidly advancing in the USA, with two drugs, psilocybin and MDMA, progressing through a structure of FDA-approved trials on a trajectory toward Drug Enforcement Agency rescheduling for therapeutic use. Researcher’s and clinician’s personal use of psychedelics was cited as a potential confound in psychedelic research studies conducted in the 1950s and 1960s, a concern which contributed to the cessation of this research for some 20 years. Currently, there is no [...]

Lire la suite

Menace or medicine? Anthropological perspectives on the self-administration of high potency cannabis in the UK, Anna Waldstein, 2010

Menace or medicine? Anthropological perspectives on the self-administration of high potency cannabis in the UK Anna Waldstein Drugs and Alcohol Today • Volume 10 Issue 3 • September 2010   Abstract Domestically produced, high potency cannabis (often referred to as ‘skunk’ in the mainstream UK media) has become increasingly widespread in the UK. This paper considers whether the trend reflects an increased awareness of and desire for medical marijuana. Determining whether cannabis is a drug or a medicine depends on its objective physiological effects – which may vary from one individual to another – as well as how and why those effects are experienced. The [...]

Lire la suite

Awareness of Emotional Expressions in Cannabis Users: An Event-Related Potential Study, Robert D. Torrence et al., 2019 ,

Awareness of Emotional Expressions in Cannabis Users : An Event-Related Potential Study Robert D. Torrence, Donald C. Rojas and Lucy J. Troup Frontiers in Psychology, February 2019 | Volume 10 | Article 69 ORIGINAL RESEARCH doi: 10.3389/fpsyg.2019.00069 Abstract Cannabis use has been associated with anxiogenic effects when used in low frequency for a short duration, but cannabis can also have anxiogenic effects when used heavily for a long duration. Animal studies have indicated the neurobiological mechanisms related to cannabis and anxiety; however, research has been limited on the related neurocognitive mechanisms. Previous research has indicated that cannabis use is associated with alterations in event-related potentials (ERPs). [...]

Lire la suite

Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states, Yuliya Zaytseva et al., 2019

Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states Zaytseva Y; Horáček J; Hlinka J; Fajnerová I; Androvičová R; Tintěra J; Salvi V; Balíková M; Hložek T; Španiel F; Páleníček T  Journal of Psychopharmacology, 2019, 33, 7, 811-821 Research Article  doi: 10.1177/0269881119849814. Abstract : Background : Cannabis, and specifically one of its active compounds delta-9-tetrahydrocannabinol in recreational doses, has a variety of effects on cognitive processes. Most studies employ resting state functional magnetic resonance imaging techniques to assess the stationary effects of cannabis and to-date one report addressed the impact of delta-9-tetrahydrocannabinol on the dynamics of whole-brain functional connectivity. Methods : Using a [...]

Lire la suite

Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States, Nora D. Volkow et al., 2019

RESEARCH LETTER Self-reported Medical and Non-medical Cannabis Use Among Pregnant Women in the United States JAMA, Published online June 18, 2019. doi: 10.1001/jama.2019.7982 Cannabis use increased among pregnantwomenin the United States from2002 to 2014.1 However, changes in cannabis use and frequency by trimester over time and national prevalence of medical cannabis use during pregnancy are unknown. Data fromtheNational Survey on Drug Use andHealth (NSDUH) were examined to address these knowledge gaps. Methods : Data were from women aged 12 to 44 years who participated in the 2002-2017 NSDUH, a representative survey of the US civilian, noninstitutionalized population.2 Collection of NSDUH data was approved [...]

Lire la suite

Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes, Daniel J. Corsi et al., 2019

Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes Daniel J. Corsi, PhD; LauraWalsh, MSc; DeborahWeiss, PhD; Helen Hsu, MD; Darine El-Chaar, MD; Steven Hawken, PhD; Deshayne B. Fell, PhD; MarkWalker,MD JAMA,  Published online June 18, 2019. doi:10.1001/jama.2019.8734   Key Points Question  Is there an association between prenatal cannabis exposure and maternal, perinatal, and neonatal outcomes? Findings  In this retrospective cohort study that included 661 617 pregnancies and 9427 reported cannabis users, the rate of preterm birth among reported cannabis users was 12% vs 6% in nonusers, a statistically significant difference. Meaning  Reported cannabis use in pregnancy was associated with significant increases in the rate of preterm [...]

Lire la suite

Essais pilotes avec du cannabis: premier obstacle franchi, CSSS-N Commissions de la sécurité sociale et de la santé publique, Berne, Suisse, 3 mai 2019

CSSS-N Commissions de la sécurité sociale et de la santé publique Secrétariat CH-3003 Berne www.parlament.ch sgk.csss@parl.admin.ch Vendredi, 03 mai 2019 15h50 Communiqué de presse Essais pilotes avec du cannabis: premier obstacle franchi La Commission de la sécurité sociale et de la santé publique du Conseil national est entrée en matière sur le projet prévoyant la création d’un article relatif aux projets pilotes dans la loi sur les stupéfiants. Elle souhaite permettre la réalisation d’études scientifiques sur la remise contrôlée de cannabis en vue d’une consommation récréative. Par 12 voix contre 9 et 2 abstentions, la Commission de la sécurité sociale et de la santé publique [...]

Lire la suite